20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BECLOMETHASONE DIPROPIONATE USP (ANHYDROUS), with a corresponding US DMF Number 28928.
Remarkably, this DMF maintains an Active status since its submission on February 27, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 12, 2018, and payment made on December 18, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II